Actively Recruiting
Study of Everolimus and Resistance Training to Improve Bone and Muscle Health in Women Aged 60 to 75 Years
Led by Odense University Hospital · Updated on 2026-04-06
148
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether everolimus, resistance training, or their combination can improve bone formation and muscle function in elderly women aged 60 to 75 years. This phase 2 clinical trial focuses on postmenopausal women with low bone mass but not osteoporosis. It aims to compare these treatments against placebo controls to see if they enhance bone and muscle health. Participants will be randomly assigned to one of four groups oral everolimus 5 mg once a week, oral placebo once a week, everolimus plus resistance training 1 hour, 3 times per week, or placebo plus resistance training. The treatment period lasts 24 weeks. Resistance training is supervised and combined with the drug or placebo intake to assess potential combined effects. During the study, participants will attend 5 to 7 visits where they will have blood samples taken, undergo various scans including DXA, HRpQCT, and MRI, and provide muscle and bone biopsies. They will complete quality of life questionnaires and muscle function tests. Researchers will monitor bone and muscle health markers, metabolic health, and muscle and bone protein turnover throughout the 24-week treatment period.
CONDITIONS
Brief Title
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Research Team
S
Sofie Elkjær, MD
M
Maria Østergaard Madsen, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here